A phase 1b clinical trial to determine the safety, tolerability and immunogenicity of simian adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies in patients with active Crohn's disease.
Saved in:
| Title: | A phase 1b clinical trial to determine the safety, tolerability and immunogenicity of simian adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies in patients with active Crohn's disease. |
|---|---|
| Authors: | Sanderson J; Guy's and St Thomas' Hospitals NHS Foundation Trust, Great Maze Pond, London SE1 9RT, UK., Aboagye J; The Jenner Institute, ORCRB, University of Oxford, Oxford, OX3 7DQ, UK., Makinson R; The Jenner Institute, ORCRB, University of Oxford, Oxford, OX3 7DQ, UK., Rapi K; The Jenner Institute, ORCRB, University of Oxford, Oxford, OX3 7DQ, UK., Provstgaard-Morys S; The Jenner Institute, ORCRB, University of Oxford, Oxford, OX3 7DQ, UK., Stockdale L; The Jenner Institute, ORCRB, University of Oxford, Oxford, OX3 7DQ, UK., Alison Lawrie; The Jenner Institute, ORCRB, University of Oxford, Oxford, OX3 7DQ, UK., Lanigan I; Guy's and St Thomas' Hospitals NHS Foundation Trust, Great Maze Pond, London SE1 9RT, UK., Halim N; Guy's and St Thomas' Hospitals NHS Foundation Trust, Great Maze Pond, London SE1 9RT, UK., Douiri A; Kings College London, Great Maze Pond, London SE1 1UL, UK., Greenlay E; Kings College London, Great Maze Pond, London SE1 1UL, UK., Malek R; Kings College London, Great Maze Pond, London SE1 1UL, UK., Gray E; Kings College London, Great Maze Pond, London SE1 1UL, UK., West L; Kings College London, Great Maze Pond, London SE1 1UL, UK., El Oulidi F; HAV Vaccines Limited, Np-105, Icentre, Howard Way, Newport Pagnell, Milton Keynes MK16 9PY, UK., Cross PI; HAV Vaccines Limited, Np-105, Icentre, Howard Way, Newport Pagnell, Milton Keynes MK16 9PY, UK. Electronic address: paul@pauliancross.com., Stallibrass M; HAV Vaccines Limited, Np-105, Icentre, Howard Way, Newport Pagnell, Milton Keynes MK16 9PY, UK., Gilbert SC; The Jenner Institute, ORCRB, University of Oxford, Oxford, OX3 7DQ, UK., Hill AVS; The Jenner Institute, ORCRB, University of Oxford, Oxford, OX3 7DQ, UK., Ewer KJ; The Jenner Institute, ORCRB, University of Oxford, Oxford, OX3 7DQ, UK. |
| Source: | EBioMedicine [EBioMedicine] 2025 Mar; Vol. 113, pp. 105570. Date of Electronic Publication: 2025 Feb 07. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39922068 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A phase 1b clinical trial to determine the safety, tolerability and immunogenicity of simian adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies in patients with active Crohn's disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sanderson+J%22">Sanderson J</searchLink>; Guy's and St Thomas' Hospitals NHS Foundation Trust, Great Maze Pond, London SE1 9RT, UK.<br /><searchLink fieldCode="AU" term="%22Aboagye+J%22">Aboagye J</searchLink>; The Jenner Institute, ORCRB, University of Oxford, Oxford, OX3 7DQ, UK.<br /><searchLink fieldCode="AU" term="%22Makinson+R%22">Makinson R</searchLink>; The Jenner Institute, ORCRB, University of Oxford, Oxford, OX3 7DQ, UK.<br /><searchLink fieldCode="AU" term="%22Rapi+K%22">Rapi K</searchLink>; The Jenner Institute, ORCRB, University of Oxford, Oxford, OX3 7DQ, UK.<br /><searchLink fieldCode="AU" term="%22Provstgaard-Morys+S%22">Provstgaard-Morys S</searchLink>; The Jenner Institute, ORCRB, University of Oxford, Oxford, OX3 7DQ, UK.<br /><searchLink fieldCode="AU" term="%22Stockdale+L%22">Stockdale L</searchLink>; The Jenner Institute, ORCRB, University of Oxford, Oxford, OX3 7DQ, UK.<br /><searchLink fieldCode="AU" term="%22Alison+Lawrie%22">Alison Lawrie</searchLink>; The Jenner Institute, ORCRB, University of Oxford, Oxford, OX3 7DQ, UK.<br /><searchLink fieldCode="AU" term="%22Lanigan+I%22">Lanigan I</searchLink>; Guy's and St Thomas' Hospitals NHS Foundation Trust, Great Maze Pond, London SE1 9RT, UK.<br /><searchLink fieldCode="AU" term="%22Halim+N%22">Halim N</searchLink>; Guy's and St Thomas' Hospitals NHS Foundation Trust, Great Maze Pond, London SE1 9RT, UK.<br /><searchLink fieldCode="AU" term="%22Douiri+A%22">Douiri A</searchLink>; Kings College London, Great Maze Pond, London SE1 1UL, UK.<br /><searchLink fieldCode="AU" term="%22Greenlay+E%22">Greenlay E</searchLink>; Kings College London, Great Maze Pond, London SE1 1UL, UK.<br /><searchLink fieldCode="AU" term="%22Malek+R%22">Malek R</searchLink>; Kings College London, Great Maze Pond, London SE1 1UL, UK.<br /><searchLink fieldCode="AU" term="%22Gray+E%22">Gray E</searchLink>; Kings College London, Great Maze Pond, London SE1 1UL, UK.<br /><searchLink fieldCode="AU" term="%22West+L%22">West L</searchLink>; Kings College London, Great Maze Pond, London SE1 1UL, UK.<br /><searchLink fieldCode="AU" term="%22El+Oulidi+F%22">El Oulidi F</searchLink>; HAV Vaccines Limited, Np-105, Icentre, Howard Way, Newport Pagnell, Milton Keynes MK16 9PY, UK.<br /><searchLink fieldCode="AU" term="%22Cross+PI%22">Cross PI</searchLink>; HAV Vaccines Limited, Np-105, Icentre, Howard Way, Newport Pagnell, Milton Keynes MK16 9PY, UK. Electronic address: paul@pauliancross.com.<br /><searchLink fieldCode="AU" term="%22Stallibrass+M%22">Stallibrass M</searchLink>; HAV Vaccines Limited, Np-105, Icentre, Howard Way, Newport Pagnell, Milton Keynes MK16 9PY, UK.<br /><searchLink fieldCode="AU" term="%22Gilbert+SC%22">Gilbert SC</searchLink>; The Jenner Institute, ORCRB, University of Oxford, Oxford, OX3 7DQ, UK.<br /><searchLink fieldCode="AU" term="%22Hill+AVS%22">Hill AVS</searchLink>; The Jenner Institute, ORCRB, University of Oxford, Oxford, OX3 7DQ, UK.<br /><searchLink fieldCode="AU" term="%22Ewer+KJ%22">Ewer KJ</searchLink>; The Jenner Institute, ORCRB, University of Oxford, Oxford, OX3 7DQ, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101647039%22">EBioMedicine</searchLink> [EBioMedicine] 2025 Mar; Vol. 113, pp. 105570. <i>Date of Electronic Publication: </i>2025 Feb 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101647039 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2352-3964 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223523964%22">23523964 </searchLink><i>NLM ISO Abbreviation: </i>EBioMedicine <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39922068 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ebiom.2025.105570 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 105570 Titles: – TitleFull: A phase 1b clinical trial to determine the safety, tolerability and immunogenicity of simian adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies in patients with active Crohn's disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sanderson J – PersonEntity: Name: NameFull: Aboagye J – PersonEntity: Name: NameFull: Makinson R – PersonEntity: Name: NameFull: Rapi K – PersonEntity: Name: NameFull: Provstgaard-Morys S – PersonEntity: Name: NameFull: Stockdale L – PersonEntity: Name: NameFull: Alison Lawrie – PersonEntity: Name: NameFull: Lanigan I – PersonEntity: Name: NameFull: Halim N – PersonEntity: Name: NameFull: Douiri A – PersonEntity: Name: NameFull: Greenlay E – PersonEntity: Name: NameFull: Malek R – PersonEntity: Name: NameFull: Gray E – PersonEntity: Name: NameFull: West L – PersonEntity: Name: NameFull: El Oulidi F – PersonEntity: Name: NameFull: Cross PI – PersonEntity: Name: NameFull: Stallibrass M – PersonEntity: Name: NameFull: Gilbert SC – PersonEntity: Name: NameFull: Hill AVS – PersonEntity: Name: NameFull: Ewer KJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2025 Mar Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2352-3964 Numbering: – Type: volume Value: 113 Titles: – TitleFull: EBioMedicine Type: main |
| ResultId | 1 |